Abstract
Rational design in protein engineering leads to significant progresses in medicinal chemistry research.It alleviates the difficulty of exploring unreasonable biological functions.Combining with analysis of biophysical-chemical properties,a three-dimensional (3D)structure provides fruitful information for rational design by revealing functionally important residues.Comparative (homology)modeling,one of the 3D structural prediction techniques,takes advantage of that homologous proteins share similarity in their 3D structures despite the lack of sequence similarity.Of the most value,3D models provide functional clues even though the function may have been modified during evolution. We illustrate here two applications to medicinal chemistry research where comparative models made a significant improvement on the understanding of relevant biological functions of two proteins.These multiple collaborative projects involve the identification of solvent-exposed residues in a membrane anchoring domain of human coagulation factor V,and revealing critical residues in the interfaces of an antibody and a polynuclear aromatic hydrocarbon ligand.Since the protocol of comparative modeling technique we employed is essential to proposing useful hypotheses for experimental testing,we also present our methodology underlying our modeling programs.Our results show that inaccuracies in comparative models do not hamper functional evaluation as long as an in depth analysis of 3D structures is performed.
Keywords: homology modeling, three-dimensional structure, crystal structure, coagulation cascade, factor v, antibody, polynuclear aromatic hydrocarbons, pah
Current Medicinal Chemistry
Title: Identification of Functionally Important Residues in Proteins Using Comparative Models
Volume: 11 Issue: 5
Author(s): Shu-wen W. Chen and Jean -Luc Pellequer
Affiliation:
Keywords: homology modeling, three-dimensional structure, crystal structure, coagulation cascade, factor v, antibody, polynuclear aromatic hydrocarbons, pah
Abstract: Rational design in protein engineering leads to significant progresses in medicinal chemistry research.It alleviates the difficulty of exploring unreasonable biological functions.Combining with analysis of biophysical-chemical properties,a three-dimensional (3D)structure provides fruitful information for rational design by revealing functionally important residues.Comparative (homology)modeling,one of the 3D structural prediction techniques,takes advantage of that homologous proteins share similarity in their 3D structures despite the lack of sequence similarity.Of the most value,3D models provide functional clues even though the function may have been modified during evolution. We illustrate here two applications to medicinal chemistry research where comparative models made a significant improvement on the understanding of relevant biological functions of two proteins.These multiple collaborative projects involve the identification of solvent-exposed residues in a membrane anchoring domain of human coagulation factor V,and revealing critical residues in the interfaces of an antibody and a polynuclear aromatic hydrocarbon ligand.Since the protocol of comparative modeling technique we employed is essential to proposing useful hypotheses for experimental testing,we also present our methodology underlying our modeling programs.Our results show that inaccuracies in comparative models do not hamper functional evaluation as long as an in depth analysis of 3D structures is performed.
Export Options
About this article
Cite this article as:
Chen W. Shu-wen and Pellequer -Luc Jean, Identification of Functionally Important Residues in Proteins Using Comparative Models, Current Medicinal Chemistry 2004; 11 (5) . https://dx.doi.org/10.2174/0929867043455891
DOI https://dx.doi.org/10.2174/0929867043455891 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anesthetic Cardioprotection in Clinical Practice From Proof-of-Concept to Clinical Applications
Current Pharmaceutical Design Biomarkers Associated with Vulnerable Atheromatous Plaque
Current Medicinal Chemistry Invasive and Noninvasive Assessment of Exercise-induced Ischemic Diastolic Response Using Pressure Transducers
Current Cardiology Reviews Lifelong Endocrine Fluctuations and Related Cognitive Disorders
Current Pharmaceutical Design Pharmacological and Biological Activities of Benzazepines: An Overview
Current Bioactive Compounds Antioxidant Treatment and Endothelial Dysfunction: Is it Time for Flavonoids?
Recent Patents on Cardiovascular Drug Discovery Translational Application of In Vivo Imaging and Analysis of Atherosclerotic Plaque Vulnerability Assessment
Recent Patents on Medical Imaging Relationships between Serotoninergic System and Skin Fibrotic
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Effects of Obesity-Related Peptides on the Vasculature
Current Vascular Pharmacology Nano-Systems for Advanced Therapeutics and Diagnosis of Atherosclerosis
Current Pharmaceutical Design An Update on the Cardiovascular Effects of Quercetin, a Plant Flavonoid
Current Nutrition & Food Science Non-invasive Estimation of Aortic Blood Pressures: A Close Look at Current Devices and Methods
Current Pharmaceutical Design Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement
Current Vascular Pharmacology Influenza and Stroke Risk: A Key Target Not to be Missed?
Infectious Disorders - Drug Targets β-Lactam Cholesterol Absorption Inhibitors
Current Medicinal Chemistry The Blockade of Renin-Angiotensin-Aldosterone System in Hemodialysis Patients to Control Hypertension and Prevent Cardiovascular Disease: Optimal Pharmacotherapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Ezetimibe and Reactive Oxygen Species
Current Vascular Pharmacology Therapeutic Implications of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, for Various Immune-Mediated Diseases: An Update Review
Current Rheumatology Reviews Cerebrovascular Complications of Diabetes: SGLT-2 Inhibitors as a Promising Future Therapeutics
Current Drug Targets Psychosocial Risk Factors Related to Ischemic Heart Disease in Women
Current Pharmaceutical Design